SignalEU/UK

Olema Pharmaceuticals Shares Fall 15.1% Following AstraZeneca SERENA-4 Trial Results

Olema shares drop 15.1% on AstraZeneca SERENA-4 trial results.

What changed

Olema shares drop 15.1% on AstraZeneca SERENA-4 trial results.

Why it matters

Olema shares drop 15.1% on AstraZeneca SERENA-4 trial results. — impact context not separately stored; see What changed.

Sources